Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high‐dose methotrexate therapy in open‐label trials-Reference-Cited by-同舟云学术

Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high‐dose methotrexate therapy in open‐label trials

Published:2023-10-05 Issue:12 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Janeway Katherine A.¹^ORCID,Gros Luis²,Schwartz Stefan³,Daugherty Claire⁴,Gallardo Eva⁵,Hill Christon⁴,Thomas Emma⁵^ORCID,Ward Suzanne⁴,Rizzari Carmelo⁶⁷^ORCID

Affiliation:

1. Dana‐Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School Boston Massachusetts USA

2. Vall d'Hebron Research Institute and Department of Pediatric Hematology and Oncology Vall d'Hebron University Hospital Barcelona Spain

3. Department of Hematology Oncology and Tumor Immunology Charité ‐ Universitätsmedizin Berlin corporate member of Freie Universität and Humboldt‐Universität zu Berlin Campus Benjamin Franklin Berlin Germany

4. BTG International Inc. Conshohocken PA USA

5. Protherics Medicines Development Ltd. London UK

6. Unit of Pediatrics Foundation IRCCS San Gerardo dei Tintori Monza Italy

7. Department of Medicine and Surgery University of Milano‐Bicocca Monza Italy

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30662

Reference8 articles.

1. Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high‐dose methotrexate therapy in open‐label trials;Meyers PA;Pediatr Blood Cancer,2023

2. High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course

3. Management of Patients with Acute Methotrexate Nephrotoxicity with High-Dose Leucovorin

4. Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

5. How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia